Understand the source comparison
Evidence-Based Dosing for Jet Lag Versus Insomnia
Clinical trials specifically measuring jet lag recovery have consistently used lower melatonin doses than those marketed for general insomnia. The effective range for circadian phase shifting appears to be 0.5mg to 3mg, taken once daily at the target bedtime i
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Clinical trials specifically measuring jet lag recovery have consistently used lower melatonin doses than those marketed for general insomnia. The effective range for circadian phase shifting appears to be 0.5mg to 3mg, taken once daily at the target bedtime in the new time zone. Higher doses. 5mg, 10mg, or the commonly sold 10mg sustained-release formulations. Do not produce faster or stronger phase shifts and may increase next-day grogginess without improving circadian alignment.
- The distinction between chronobiotic dosing and hypnotic dosing is critical. Melatonin's sedative effects occur at doses above 3mg and involve non-receptor-mediated mechanisms including GABAergic modulation and histamine receptor interaction. These effects produce subjective sleepiness but do not accelerate circadian re-entrainment. A traveler taking 10mg melatonin may fall asleep faster on night one, but their circadian clock. Governing cortisol release, core body temperature rhythm, and cognitive performance peaks. Will take the same number of days to adjust as someone taking 0.5mg at the correct circadian window.
- A landmark 2019 Cochrane Review aggregating 11 randomized controlled trials (n=796) found that melatonin doses between 0.5mg and 5mg reduced jet lag severity scores by 50–60% compared to placebo when crossing five or more time zones eastward. The review found no dose-response relationship above 0.5mg. Suggesting that 0.5mg is as effective as 5mg for phase shifting. One additional consideration: melatonin has a short half-life of 40–60 minutes, meaning sustained-release formulations miss the narrow circadian timing window that makes the intervention effective in the first place. Immediate-release formulations taken at precise times outperform sustained-release taken at the same nominal time.
- For researchers exploring circadian biology at the molecular level, peptides like Pinealon. Studied for effects on pineal gland function. Represent tools for investigating endogenous melatonin regulation rather than exogenous supplementation.